An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro

This work illustrates the development of a dry inhalation powder of cyclosporine-A for the prevention of rejection after lung transplantation and for the treatment of COVID-19. The influence of excipients on the spray-dried powder’s critical quality attributes was explored. The best-performing powde...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Angelo, Davide, Quarta, Eride, Glieca, Stefania, Varacca, Giada, Flammini, Lisa, Bertoni, Simona, Brandolini, Martina, Sambri, Vittorio, Grumiro, Laura, Gatti, Giulia, Dirani, Giorgio, Taddei, Francesca, Bianchera, Annalisa, Sonvico, Fabio, Bettini, Ruggero, Buttini, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055879/
https://www.ncbi.nlm.nih.gov/pubmed/36986883
http://dx.doi.org/10.3390/pharmaceutics15031023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055879/
https://www.ncbi.nlm.nih.gov/pubmed/36986883
http://dx.doi.org/10.3390/pharmaceutics15031023

Ejemplares similares